Skip to main content

Day: May 25, 2022

Introducing Cloudbeds Amplify: The Intelligent Digital Marketing Solution Driving More Direct Bookings for Independent Hoteliers

Leading hotel technology platform Cloudbeds acquires AdsHotel and Odysys to level the playing field in the high-cost competition for direct bookings with new digital marketing serviceIntroducing Cloudbeds Amplify: a done-for-you digital marketing service run by a partner you trust.SAN DIEGO, May 25, 2022 (GLOBE NEWSWIRE) — Cloudbeds, the hospitality industry’s fastest-growing technology provider, unveiled today the expansion of its hospitality platform with its newest solution, Cloudbeds Amplify. Set for release in early Fall, the comprehensive done-for-you digital marketing service leverages advanced technologies to optimize customers’ online presence, drive more direct bookings and increase revenue. Cloudbeds Amplify services include website creation and search optimization, metasearch advertising, search...

Continue reading

Canadian Banc Corp. Announces TSX Acceptance of Normal Course Issuer Bid

TORONTO, May 25, 2022 (GLOBE NEWSWIRE) — Canadian Banc Corp. (the “Company”) announced today that the Toronto Stock Exchange (the “TSX”) has accepted its notice of intention to make a Normal Course Issuer Bid (the “NCIB”) to purchase its Preferred Shares and Class A Shares through the facilities of the TSX and/or alternative Canadian trading systems. The NCIB will commence on May 27, 2022 and terminate on May 26, 2023. Pursuant to the NCIB, the Company proposes to purchase, from time to time, if it is considered advisable, up to 1,259,931 Preferred Shares and 1,255,482 Class A Shares of the Company, representing 10% of the public float of 12,599,311 Preferred Shares and 12,554,829 Class A Shares. As of May 13, 2022, there were 12,621,882 Preferred Shares and 12,602,282 Class A Shares issued and outstanding. The Company will not...

Continue reading

Science 37® to Present at the William Blair 42nd Annual Growth Stock Conference

RESEARCH TRIANGLE PARK, N.C., May 25, 2022 (GLOBE NEWSWIRE) — Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™, today announced the company will be participating in the upcoming William Blair Growth Stock Conference in Chicago. Science 37’s management is scheduled to present on Wednesday, June 8, 2022, at 3:20 p.m. Central Time. Interested parties may access a live and archived webcast of the presentation on the “Investor Relations” section of the company’s website at: https://investors.science37.com. About Science 37Science 37 Holdings, Inc.’s (Nasdaq: SNCE) mission is to enable universal access to clinical research—making it easier for patients and providers to participate from anywhere and helping to accelerate the development of treatments that impact patient lives. As a pioneer of decentralized...

Continue reading

Small Pharma Shares Business Update Ahead of Annual Financial Results

– Appointment of Alastair Riddell as COO– Two new Composition of Matter patents granted for pipeline projects– Progress continues across short-acting psychedelics portfolio LONDON, May 25, 2022 (GLOBE NEWSWIRE) — Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “Company” or “Small Pharma”), a biotechnology company focused on short-acting psychedelic-assisted therapies for mental health conditions, provides a business update ahead of its annual financial results for the fiscal year ended February 28, 2022. All references to “$” in this press release refer to Canadian dollars unless otherwise indicated. Strengthening the Team Small Pharma has appointed Dr. Alastair Riddell as Chief Operating Officer of the Company. Dr. Riddell joins the management team with over 30 years of international leadership experience...

Continue reading

LexaGene Announces Multi-System Purchase from a Large Market Leader in Animal Health

BEVERLY, Mass., May 25, 2022 (GLOBE NEWSWIRE) — LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), a molecular diagnostics company that has commercialized an instrument for automated multiplex PCR testing, is pleased to announce a large veterinary animal health corporation has purchased 2 MiQLab® Systems for two of their locations. Both locations will use the MiQLab Systems for fast evidence-based decision making at the point of care. The MiQLab System is designed for in-clinic use, requires less than a minute to initiate sample processing, and returns results on the presence of 10 different pathogens and 33 markers for antimicrobial resistance in just 2 hours. Dr. Jack Regan, LexaGene’s CEO and Founder stated, “A month ago, we announced our first multi-system purchase into one of the three major...

Continue reading

Three Valley Copper Reports 2022 First Quarter Results and Provides Corporate Update

(all amounts expressed in US dollars) TORONTO, May 25, 2022 (GLOBE NEWSWIRE) — (TSXV: TVC) (OTCQB: TVCCF) Three Valley Copper Corp. (“TVC” or the “Company“) today announced its operating and financial results for the three months ended March 31, 2022. The Company is focused on growing copper production from, and further exploration of, its primary asset, Minera Tres Valles SpA (“MTV“). Located in Salamanca, Chile, MTV is 95.1% owned by the Company and MTV’s main assets are the Minera Tres Valles mining complex and its 46,000 hectares of exploratory lands. The Company’s financial statements and management’s discussion and analysis (“MD&A“) are available at www.threevalleycopper.com and www.sedar.com. Highlights CorporateThe initial construction of the Papomono...

Continue reading

Koios Provides Q3 2022 Summary Including Improved Financials

Koios is delighted to report positive updates regarding its financial performance in its Q3 2022, in which it saw revenue growth of 278%, a 164% increase in gross margins, and reductions in several expense categories DENVER and VANCOUVER, British Columbia, May 25, 2022 (GLOBE NEWSWIRE) — Koios Beverage Corp. (CSE: FIT; OTC: FITSF) (the “Company” or “Koios”) hereby provides an overview of its financial status as at the end of its third quarter for the interim period ended February 28, 2022 (“Q3 2022”). The Company’s management is pleased to report significant growth in revenue, improvements to gross margin, reduced expenses, and strong cash holdings with minimal debt liabilities. With the recent addition of new products and an expansion of the Company’s retail and distribution footprint,...

Continue reading

Jushi Holdings Inc. Reports First Quarter 2022 Financial Results

First Quarter 2022 Revenue Increased 48.5% to $61.9 million as Compared to the First Quarter of 2021 Established Fourth Vertically Integrated State-Level Operation in Nevada with the Completion of the Acquisition of The Apothecarium(2) dispensary in Las Vegas BOCA RATON, Fla., May 25, 2022 (GLOBE NEWSWIRE) — Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF), a vertically integrated, multi-state cannabis operator, is pleased to announce its financial results for the first quarter 2022 (“Q1 2022”) ended March 31, 2022. All financial information is provided in U.S. dollars unless otherwise indicated. First Quarter 2022 HighlightsTotal revenue of $61.9 million, an increase of 48.5% year-over-year Adjusted gross profit(1) of $25.5 million, an increase of 33.1% year-over-year Net loss of $14.3 million Adjusted...

Continue reading

Belships ASA: New acquisition and divestment of vessel

Belships has entered into an agreement for the acquisition of a modern 64 000 dwt Ultramax bulk carrier built at a Japanese shipyard in 2020. The vessel is financed through a time charter lease agreement for a fixed period of about 5 years with options to extend for a further 3 years. Belships will pay a total of USD 6.0m prior to delivery of the vessel. Cash breakeven for the vessel upon delivery will be about USD 11 600 per day. The agreement comes with an option to purchase the vessel at the end of the charter significantly below current market levels. There is no obligation to purchase the vessel. The vessel comes with time charter contract employment for about 10-12 months at a gross rate of USD 30 000 per day. The agreement is conditional upon certain steps to be completed by the parties involved. Delivery of the vessel is expected...

Continue reading

TYME Technologies, Inc. Reports Fourth Fiscal Quarter and Full Year 2022 Financial and Operating Results

— $84.0 million in cash and marketable securities as of March 31, 2022 — BEDMINSTER, N.J., May 25, 2022 (GLOBE NEWSWIRE) — TYME Technologies, Inc. (Nasdaq: TYME) (the Company or TYME), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™), announced financial and operating results for its fourth fiscal quarter and full year ended March 31, 2022. In March the Company announced that its Board of Directors decided to explore potential strategic options to enhance stockholder value, and this process is active and ongoing. The Company plans to provide an update upon completion of this process. Fourth Fiscal Quarter and Full Year 2022 Financial Results As of the quarter ended March 31, 2022, the Company had approximately $84.0 million in cash and marketable securities, compared to $92.0...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.